Bradley Bart, MD, graduated from medical school at the University of Minnesota in 1990 and received his internal medicine training at the University of Colorado in Denver. He completed his cardiology fellowship at Duke University in Durham, North Carolina and has been a faculty member at Hennepin County Medical Center since 1997. He is a Chief of Cardiology at HCMC, Professor of Medicine at the University of Minnesota and a fellow of the American College of Cardiology. Dr. Bart is board certified in internal medicine, cardiology and nuclear cardiology.
Steven Goldsmith, MD, graduated from Ohio State University where he also completed his residency training in internal medicine. He received a fellowship in cardiology from the University of Minnesota. Dr. Goldsmith is a staff member in the Division of Cardiology at HCMC, a Professor of Medicine at the University of Minnesota, and director of the Minnesota Heart Failure Consortium.
Heart failure is an immense and growing medical problem in the US. It affects nearly 5 million people with approximately 500,000 new cases diagnosed each year. It is a progressive condition where the heart has been damaged by disease or injury and cannot pump enough blood and oxygen to meet the body’s needs. Health care costs associated with heart failure are estimated to be as high as $23 billion annually.
Steven Goldsmith is a national leader in heart failure research. He is the Medical Director of the Minnesota Heart Failure Consortium (MHFC) – a network of Minnesota researchers committed to advancing our understanding of heart failure and how to treat it. Dr. Goldsmith works closely with Bradley Bart, a leading cardiologist and Hennepin County Medical Center physician.
Drs. Goldsmith and Bart are conducting translational research projects to try to reduce the impact of heart failure by developing new medicine and medical treatments that can be directly put to use by physicians to improve patient outcomes.
Many innovative strategies to improve heart function in heart failure patients have emerged in past years. However, patients have not benefited from these advances because large clinical trials have not been conducted to verify their effectiveness and safety in humans.
*HHRI is not responsible for the content on external websites. The appearance of these links on the HHRI website does not constitute an endorsement by HHRI.